Stocksigma LogoStocksigma Logo

Speciality Medicines Secures Ethiopian Approval for Two Formulations

Speciality Medicines (SPML) announced on 12 Aug'26 that it received regulatory approval from Ethiopian health authorities for two new products: Olanzapine

Speciality Medicines Secures Ethiopian Approval for Two Formulations

Speciality Medicines Ltd 路 Others (Uncategorized) 路 12 Aug 2026, 10:37 pm

Speciality Medicines Secures Ethiopian Approval for Two Formulations Speciality Medicines (SPML) announced on 12 Aug'26 that it received regulatory approval from Ethiopian health authorities for two new products: Olanzapine 5 mg (Olazyn 5) and Diazepam 5 mg (Diazem 5). This approval expands the company's registered product portfolio in Ethiopia to 12 formulations, strengthening its presence in a key export market. The company continues to advance its international portfolio, which also includes two registered products in Peru, reinforcing its export-focused strategy across semi-regulated global markets.

Original exchange filing (PDF)

More announcements from Speciality Medicines Ltd

All Speciality Medicines Ltd announcements